Loading
Loading
Your feedback directly shapes Sporos.
Sign in to track your feedback history
This proposed rule would revise the Medicare Advantage (Part C), Medicare Prescription Drug Benefit (Part D), and Medicare cost plan regulations to implement changes related to Star Ratings, marketing and communications, drug coverage, enrollment processes, special needs plans, and other programmatic areas.
Published
Nov 28, 2025
Comments Close
Jan 26, 2026
Citation
90 FR 54894
Agencies
2
Full text not available in our database.
View on Federal Register →Get a plain-English explanation of what this regulation does, which agencies are responsible, and how it affects existing rules.
No document text available yet
CMS-4212-P
0938-AV63
42 CFR 422
42 CFR 423